StockNews.com began coverage on shares of Veradigm (NASDAQ:MDRX - Free Report) in a research note published on Wednesday morning. The firm issued a hold rating on the software maker's stock.
Separately, Stephens lifted their price objective on Veradigm from $7.00 to $13.00 and gave the company an "equal weight" rating in a research note on Friday, January 31st.
Check Out Our Latest Report on MDRX
Veradigm Stock Performance
NASDAQ MDRX traded up $0.35 during trading on Wednesday, hitting $5.35. The stock had a trading volume of 584,573 shares, compared to its average volume of 1,010,997. Veradigm has a twelve month low of $4.50 and a twelve month high of $11.80. The firm has a 50 day moving average price of $8.90 and a 200 day moving average price of $9.43.
About Veradigm
(
Get Free Report)
Veradigm Inc, a healthcare technology company, provides information technology solutions and services to healthcare organizations in the United States, Canada, and internationally. It offers electronic health records (EHR), information connectivity, private cloud hosting, outsourcing, analytics, patient access, and population health management solutions.
Further Reading
Before you consider Veradigm, you'll want to hear this.
MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Veradigm wasn't on the list.
While Veradigm currently has a Hold rating among analysts, top-rated analysts believe these five stocks are better buys.
View The Five Stocks Here
MarketBeat has just released its list of 20 stocks that Wall Street analysts hate. These companies may appear to have good fundamentals, but top analysts smell something seriously rotten. Are any of these companies lurking around your portfolio?
Get This Free Report
Like this article? Share it with a colleague.
Link copied to clipboard.
